Alex Azar, nominee to be Health and Human Services secretary, takes a seat for his hearing before the Senate Health, Education, Labor and Pensions Committee on Wednesday. (Bill Clark/CQ Roll Call)
The nominee to lead the Health and Human Services Department, Alex M. Azar, told a Senate panel that his top priority would be addressing the high price of prescription drugs. But there was skepticism from both sides of the dais at Wednesday’s Health, Education, Labor and Pensions Committee hearing that Azar, a former pharmaceutical company executive, would live up to that promise.
While it was mostly Democrats who took aim at Azar’s tenure working for and running the U.S. affiliate of Eli Lilly & Co., Sen. Rand Paul said he would also need to be convinced. The Kentucky Republican pressed Azar on whether he would work on a system to safely import lower-cost prescription drugs from places with comparable systems, like Canada and Europe.